These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29464)

  • 1. Conditions for production of thermosensitive attenuated influenza virus recombinants.
    Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
    Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle.
    Polezhaev FI; Garmashova LM; Rumovsky VI; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Jun; 24(4):273-8. PubMed ID: 6106378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on some genetic properties of antigenic recombinants of influenza viruses.
    Podchernyaeva RYa ; Döhner L; Herrmann RM; Blinova VK; Ivanova VT
    Acta Virol; 1982 Jul; 26(4):227-33. PubMed ID: 6127929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
    Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
    Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in selecting safe heat-sensitive influenza virus A recombinants].
    Aleksandrova GI; Garmashova LM; Golubev DB; Koliak LI; Medvedeva TE
    Vopr Virusol; 1979; (4):342-6. PubMed ID: 483771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of influenza B virus recombinant strains.
    Podchernyaeva RYa ; Shchipanova MV; Elkin VS; Melnichenko EI
    Acta Virol; 1987 Nov; 31(6):475-80. PubMed ID: 2894141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
    Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
    Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of A/Victoria/3/75 recombinants: development of an attenuated strain RIT 4050.
    Lobmann M; Delem A; Jovanović D
    Dev Biol Stand; 1977 Jun 1-3; 39():43-6. PubMed ID: 604127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
    Garmashova LM; Polezhaev FI; Aleksandrova GI
    Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.
    Ghendon YZ; Klimov AI; Alexandrova GI; Polezhaev FI
    J Gen Virol; 1981 Apr; 53(Pt 2):215-24. PubMed ID: 7264609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on influenza-virus virulence in recombinants between epidemic and vaccine strains.
    Zazimko LA; Vakin VS; Sklyanskaya EI; Zhdanov VM
    Acta Virol; 1987 Sep; 31(5):387-96. PubMed ID: 2891277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
    Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
    Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a cold-recombinant influenza virus vaccine in ferrets.
    Maassab HF; Kendal AP; Abrams GD; Monto AS
    J Infect Dis; 1982 Dec; 146(6):780-90. PubMed ID: 7142749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
    Profeta ML; Ferrante P; Kotseva R
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.